Sacral Nerve Stimulation Market Size, Share, Trends, Industry Analysis Report: By Product Type (Device and Accessories), Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034
- Published Date:Jan-2025
- Pages: 125
- Format: PDF
- Report ID: PM5363
- Base Year: 2024
- Historical Data: 2020-2023
Sacral Nerve Stimulation Market Overview
The global sacral nerve stimulation market size was valued at USD 1,778.89 million in 2024. The market is projected to grow from USD 1,984.41 million in 2025 to USD 5,334.82 million by 2034, exhibiting a CAGR of 11.6% from 2025 to 2034.
Sacral nerve stimulation is a medical procedure that involves implanting a device to deliver electrical impulses to the sacral nerves, which can help regulate bowel and bladder function. It's often used to treat conditions such as overactive bladder, urinary incontinence, and chronic constipation when other treatments have been ineffective.
The increasing prevalence of urinary and fecal incontinence is driving the sacral nerve stimulation market growth. For instance, according to the International Foundation for Gastrointestinal Disorders, urinary incontinence affects about 10% of men and a higher percentage of women. This growing incidence, particularly among aging populations, has raised the demand for effective treatment options. As awareness about the benefits of sacral nerve stimulation in managing these conditions increases, more patients and healthcare providers are pursuing this solution, leading to the growth of the market.
The sacral nerve stimulation market is anticipated to grow significantly due to technological advancements that enhance the effectiveness and affordability of these devices. As technology becomes more sophisticated and cost-effective, adoption rates are expected to rise among healthcare providers and patients. For instance, Medtronic’s introduction of the InterStim Micro Rechargeable Sacral Neuromodulation System in August 2020 shows innovation in this field, offering improved performance and patient convenience. These advancements not only increase treatment options but also boost patient confidence in sacral nerve stimulation, positively impacting the market growth.
Sacral Nerve Stimulation Market Dynamics
Increasing Adoption of Minimally Invasive Procedures
The sacral nerve stimulation market is growing due to the increasing adoption of minimally invasive procedures. For instance, according to the National Library of Medicine, so far, minimally invasive procedures have an adoption rate of 80% to 90%. Patients and healthcare providers are increasingly looking for less invasive treatment options that offer faster recovery times and fewer complications. Sacral nerve stimulation, which is a minimally invasive procedure, has become an attractive choice for managing conditions such as urinary and fecal incontinence. This shift in preference is encouraging more healthcare facilities to adopt advanced neuromodulation therapies, thereby driving the demand for sacral nerve stimulation devices and supporting market growth.
Rising Healthcare Expenditures
Rising healthcare expenditures are driving the sacral nerve stimulation market development. For instance, according to the World Bank, healthcare expenditure has increased from 8.62% of GDP in 2000 to 10.35% in 2021globally. This growth in spending enables healthcare providers to invest in advanced medical technologies, such as sacral nerve stimulators, thereby enhancing patient care and treatment options. There is also a greater focus on innovative solutions for managing conditions like urinary and fecal incontinence as healthcare budgets expand. Thus, growing healthcare expenditure is driving the demand for sacral nerve stimulators, positively impacting the market growth.
Sacral Nerve Stimulation Market Segment Insights
Sacral Nerve Stimulation Market Evaluation Based on Product Type
The global sacral nerve stimulation market segmentation, based on product type, includes devices and accessories. The device segment is expected to experience significant growth with a high CAGR in the global market. This growth is fueled by technological advancements in device design, such as miniaturization and enhanced functionality, improving patient outcomes and satisfaction. Additionally, the introduction of innovative products with rechargeable systems is attracting more patients and healthcare providers due to the convenience, cost-effectiveness, and sustainability these systems offer, further propelling the segment’s growth in the global market.
Sacral Nerve Stimulation Market Assessment by End User Outlook
The sacral nerve stimulation market segmentation, based on end user, includes hospitals, speciality clinics, and others. The hospitals segment is expected to dominate the global market in the forecasted years. This growth is attributed to the increase in hospital admissions and extended stays for monitoring and treatment of conditions such as urinary and fecal incontinence and chronic anal fissure. Hospitals are generally in high demand due to the availability of resources and skilled professionals. Also, they are backed by large investments in the procurement of expensive machines and a skilled workforce to handle advanced machinery.
Sacral Nerve Stimulation Market Regional Analysis
By region, the study provides the sacral nerve stimulation market insights into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America accounted for the largest revenue share in the global market, driven by an increasing number of hospitals in the region. For instance, according to the American Hospital Association and the Government of Canada, North America had approximately 7,066 hospitals in 2024. This strong healthcare infrastructure supports the adoption of advanced medical technologies, including sacral nerve stimulators, as more healthcare facilities are equipped to offer these innovative treatment options.
With the growing focus on the effective management of urinary and fecal incontinence, hospitals are increasingly integrating neuromodulation therapies into their services. The rise of specialized urology and gastroenterology departments within these hospitals further supports the demand for sacral nerve stimulation, positively impacting the growth of the sacral nerve stimulation market in North America.
The Europe sacral nerve stimulation market is projected to register a substantial CAGR during the forecast period due to the increasing geriatric population. For instance, according to the European Commission, in 2023, individuals aged 65 and older constituted 21% of Europe's total population, amounting to approximately 448.8 million people. This demographic shift is fueling demand for advanced medical therapies, especially for conditions like urinary incontinence and chronic pelvic pain. As the elderly population seeks effective treatment options, healthcare providers are increasingly adopting sacral nerve stimulation technologies. Additionally, the growing awareness and acceptance of sacral nerve stimulation therapies among healthcare professionals are driving the demand for sacral nerve stimulators, positively impacting the market growth in the region.
The sacral nerve stimulation market in Germany is poised for significant growth due to rising healthcare expenditure. For instance, according to the Germany Federal Statistical Office, in 2023, the government allocated approximately USD 530 billion to the healthcare sector, averaging about USD 7,000 per person, which accounted for 12% of the country's GDP. This substantial investment enhances access to advanced medical technologies and promotes innovative treatments for conditions like chronic anal fissures and urge incontinence.
Sacral Nerve Stimulation Market – Key Players and Competitive Insights
The sacral nerve stimulation market is always evolving, with numerous companies striving to innovate and distinguish themselves. Leading global corporations dominate the market by leveraging extensive research and development, advanced manufacturing technologies, and significant capital to maintain a competitive edge. These companies pursue strategic initiatives such as mergers and acquisitions, partnerships, and collaborations to enhance their product offerings and expand into new markets.
New companies are impacting the market by introducing innovative sacral nerve stimulation devices and meeting the needs of specific market sectors. This competitive environment is amplified by continuous progress in product offerings and new applications, greater emphasis on sustainability, and the rising requirement for tailor-made single-use products in diverse industries. Major players in the sacral nerve stimulation market include Saluda Medical Pty Ltd.; Medtronic plc; Beijing PINS Medical Co., Ltd.; Axonics, Inc.; Boston Scientific Corporation; Nervo Corp.; Stimwave Technologies Inc.; St. Jude Medical; and Congentix Medical.
Medtronic, based in Dublin, Ireland, is a global medical technology company dedicated to improving patient outcomes across various therapeutic fields. Founded in 1949, the company is known for its development and manufacture of a wide collection of advanced medical devices, including pacemakers, insulin pumps, spinal implants, robotic surgical systems, and deep brain stimulation systems. Medtronic’s innovations are crucial for managing cardiovascular conditions, diabetes, neurological disorders, and spinal issues. Operating in over 150 countries, the company combines its extensive expertise with advanced research to tackle major healthcare challenges. In February 2022, Medtronic plc announced the FDA approval of the InterStim X device, improving the InterStim portfolio. This recharge-free system was launched to provide long-term sacral neuromodulation therapy for conditions like overactive bladder and chronic fecal incontinence.
Boston Scientific Corporation is a medical technology company headquartered in Marlborough, Massachusetts. Established in 1979, the company specializes in developing, manufacturing, and marketing medical devices. Its operations are structured into several key segments, including cardiovascular, endoscopy, urology and pelvic health, neuromodulation, and interventional radiology. Each segment focuses on specific medical needs, such as interventional cardiology, gastrointestinal procedures, urological conditions, pain management, and minimally invasive interventions. The company's product portfolio includes over 15,000 devices. Among its most sold products are stents and balloons, including the widely recognized Taxus drug-eluting stent, defibrillators like the EMBLEM subcutaneous implantable defibrillator; advanced endoscopic devices for gastrointestinal interventions, and neuromodulation devices for chronic pain management. Boston Scientific operates across three primary regions, which include the Americas, Europe, Asia Pacific and Middle East and Africa.
List of Key Companies in Sacral Nerve Stimulation Market
- Saluda Medical Pty Ltd.
- Medtronic plc
- Beijing PINS Medical Co., Ltd.
- Axonics, Inc.
- Boston Scientific Corporation
- Nervo Corp.
- Stimwave Technologies Inc.
- St. Jude Medical
- Congentix Medical
Sacral Nerve Stimulation Industry Developments
August 2020: Medtronic announced the U.S. launch of the FDA-approved InterStim Micro neurostimulator for sacral neuromodulation therapy. The first implant was performed at Cleveland Clinic, offering a new option for patients suffering from overactive bladder and fecal incontinence.
April 2021: The Axonics Rechargeable Sacral Neuromodulation System was introduced to overcome the drawbacks of earlier devices. It features a smaller size, MRI compatibility, and a longer battery life.
Sacral Nerve Stimulation Market Segmentation
By Product Type Outlook (Revenue – USD Million, 2020–2034)
- Devices
- Accessories
By Application Outlook (Revenue – USD Million, 2020–2034)
- Urinary and Fecal Incontinence
- Chronic Anal Fissure
- Urge Incontinence
- Others
By End User Outlook (Revenue – USD Million, 2020–2034)
- Hospitals
- Speciality Clinics
- Others
By Regional Outlook (Revenue – USD Million, 2020–2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Sacral Nerve Stimulation Market Report Scope
|
Report Attributes |
Details |
|
Market Size Value in 2024 |
USD 1,778.89 million |
|
Market Size Value in 2025 |
USD 1,984.41 million |
|
Revenue Forecast by 2034 |
USD 5,334.82 million |
|
CAGR |
11.6% from 2025–2034 |
|
Base Year |
2024 |
|
Historical Data |
2020–2023 |
|
Forecast Period |
2025–2034 |
|
Quantitative Units |
Revenue in USD million and CAGR from 2025 to 2034 |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
|
|
Regional Scope |
|
|
Competitive Landscape |
|
|
Report Format |
|
|
Customization |
Report customization as per your requirements with respect to countries, regions, and segmentation. |
FAQ's
The sacral nerve stimulation market size was valued at USD 1,778.89 million in 2024 and is projected to grow to USD 5,334.82 million by 2034.
The global market is projected to register a CAGR of 11.6% from 2025 to 2034.
North America had the largest share of the global market in 2024.
A few of the key players in the market are Saluda Medical Pty Ltd., Medtronic plc, Beijing PINS Medical Co., Ltd., Axonics, Inc., Boston Scientific Corporation, Nervo Corp., Stimwave Technologies Inc., St. Jude Medical, and Congentix Medical.
The devices segment is anticipated to experience substantial growth with a significant CAGR in the global market. This growth is due to an increase in the adoption of new devices due to miniaturization and enhanced functionality.
The hospitals segment is expected to dominate the sacral nerve stimulation market in the forecasted years.
© 2025 Polaris Market Research and Consulting. All rights reserved
